Greg Engel, Chief Executive Officer, Tilray – Medical Cannabis: Canada’s Global Leadership Opportunity
Medical cannabis is one of the world’s newest, fastest-growing and most complicated industries. It is also one of the leading contenders to strengthen Canada’s life sciences sector in terms of innovation, research, employment, and therapeutic options for patients. Greg Engel, CEO of Tilray, one of Canada’s leading licensed producers of medical cannabis, will explore what’s next for Canada and medical cannabis and how our home-grown expertise can be exported to the world. Engel will be joined in conversation by Tom Blackwell of the National Post.
Greg Engel, a pharmaceutical executive with a history of leading early-stage companies to new levels of growth, is Chief Executive Officer at Tilray, a Health Canada licensed producer and a national leader in the production and distribution of premium medical cannabis.
Through his keen business strategy, aggressive business tactics and laser-like focus on meeting and exceeding the needs and expectations of patients and physicians, Greg has successfully led the commercial efforts of four healthcare companies in Canada and globally. In the process, he has built a reputation for providing inspirational strategic and operational leadership that is grounded in a strong ethical approach.
Greg has explained his motivation to give up the world of pharmaceuticals for the uncharted course of medical cannabis quite simply: It’s challenging, groundbreaking, provocative, personal and timely. At Tilray, Greg leads a growing team of industry-leading experts working to advance the science, safety, and efficacy of medical cannabis for patients and physicians in Canada and around the world.
View webcast below:
Listen to the MP3 audio file here: